跳至主要内容
临床试验/NCT01200225
NCT01200225已完成不适用

Prospective Observational Study to Asses the Insulin Resistance (IR) and Its Impact on Sustained Virological Response in a Cohort of HCV-infected Patients Treated With Pegasys and Copegus

Hoffmann-La Roche0 个研究点目标入组 1,155 人开始时间: 2010年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,155
主要终点
Effect of insulin resistance, defined as HOMA index > 2, on sustained virological response (HCV RNA assessed by Polymerase Chain Reaction assay)

研究概览

简要总结

This prospective observational study will assess the insulin resistance and its impact on sustained virological response in patients with hepatitis C treated with Pegasys and Copegus. Data will be collected from each patient during the up to 72 weeks of treatment and for 24 weeks of treatment-free follow-up.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients, >/= 18 years of age
  • Chronic hepatitis C (detectable HCV RNA)
  • Initiation of treatment with Pegasys and Copegus

排除标准

  • Participation in a clinical trial during the study

结局指标

主要结局

Effect of insulin resistance, defined as HOMA index > 2, on sustained virological response (HCV RNA assessed by Polymerase Chain Reaction assay)

时间窗: 42 months

次要结局

  • Quality of life: Hepatitis Quality of Life Questionnaire (HQLQ)(42 months)
  • Safety: Incidence of adverse events(42 months)
  • Host-, virus- and treatment-related factors influencing virological response and sustained virological response(42 months)
  • Parameters of metabolic syndrome(42 months)
  • Management of insulin resistance(42 months)
  • Patient characteristics(42 months)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验